Publication:
"Why i am not infected with HIV": Implications for long-term HIV risk reduction and HIV vaccine trials

dc.contributor.authorDon C. Des Jarlaisen_US
dc.contributor.authorSuphak Vanichsenien_US
dc.contributor.authorMichael Marmoren_US
dc.contributor.authorAumphornphun Buaviraten_US
dc.contributor.authorSteven Titusen_US
dc.contributor.authorSuwanee Rakthamen_US
dc.contributor.authorPatricia Friedmannen_US
dc.contributor.authorDwip Kitayapornen_US
dc.contributor.authorHannah Wolfeen_US
dc.contributor.authorSamuel R. Friedmanen_US
dc.contributor.authorTimothy D. Mastroen_US
dc.contributor.otherNYU Langone Medical Centeren_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherHIV/AIDS Collaborationen_US
dc.contributor.otherBeth Israel Medical Centeren_US
dc.date.accessioned2018-07-04T07:47:22Z
dc.date.available2018-07-04T07:47:22Z
dc.date.issued1997-12-01en_US
dc.description.abstractObjective: To describe beliefs about remaining HIV-seronegative in injecting drug users in two high-seroprevalence cities, and to consider implications of these beliefs for ongoing risk reduction efforts and for HIV vaccine efficacy trials. Design: Cross-sectional survey with open- and closed-ended questions. Subjects: 58 HIV-seronegative injecting drug users participating in HIV vaccine preparation cohort studies in New York City, New York, U.S.A., and Bangkok, Thailand. Major Findings: Large majorities of subjects in Bangkok (90%) and in New York (89%) believed their "own efforts" to practice safer injection methods and safer sex were very important in avoiding HIV infection. More Bangkok subjects (30%) believed that they would "probably" become infected with HIV in the future than New York subjects (4%). Three percent of Bangkok subjects and 70% of New York subjects believed "having an immune system strong enough to avoid becoming infected with HIV despite exposure to the virus" was very important in avoiding HIV infection. This belief in New York subjects was associated with having previously engaged in high-risk behaviors (i.e., sharing injection equipment, unprotected sex, or both) with partners known to be HIV-seropositive. Conclusions: Risk reduction programming for high-HIV-seroprevalence populations and within HIV vaccine trials should address not only specific HIV risk behaviors, but also the complex belief systems about avoiding HIV infection that develop within such groups. The person's "own efforts/self-efficacy" appears to be central in the psychology of risk reduction. Members of some high-risk populations may overestimate greatly the frequency of any possible natural immunity to becoming infected with HIV. Prevention programs for these populations will need to address explicitly the probabilistic nature of HIV transmission. © 1997 Lippincott-Raven Publishers.en_US
dc.identifier.citationJournal of Acquired Immune Deficiency Syndromes. Vol.16, No.5 (1997), 393-399en_US
dc.identifier.issn15254135en_US
dc.identifier.other2-s2.0-0031445124en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/18061
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031445124&origin=inwarden_US
dc.subjectMedicineen_US
dc.title"Why i am not infected with HIV": Implications for long-term HIV risk reduction and HIV vaccine trialsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031445124&origin=inwarden_US

Files

Collections